z-logo
open-access-imgOpen Access
Costs of Tiotropium Bromide Delivered via the Respimat® Inhaler in COPD Patients in Italy
Author(s) -
Sergio Iannazzo,
Chiara Distante,
Angelo Guido Corsico
Publication year - 2016
Publication title -
global and regional health technology assessment
Language(s) - English
Resource type - Journals
eISSN - 2283-5733
pISSN - 2284-2403
DOI - 10.5301/grhta.5000220
Subject(s) - medicine , exacerbation , copd , tiotropium bromide , inhaler , intensive care medicine , emergency medicine , cost effectiveness , population , copd exacerbation , asthma , physical therapy , environmental health , acute exacerbation of chronic obstructive pulmonary disease , lung function , lung , risk analysis (engineering)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom